# US 5,348,961 A · 4-oxoquinoline-3-carboxylic acid derivatives and their use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,348,961 A
- Document ID: US5348961A
- Status: Granted
- Kind: A
- Application number: 07/594,283
- Filed: 1990-10-09
- Granted: 1994-09-20
- Earliest claimed: 1988-07-20
- Assignees: Sankyo Company, Limited
- Inventors: Masayuki Iwata; Tomio Kimura; Teruhiko Inoue; Yoshimi Fujihara; Tetsushi Katsube
- Web page: https://patentgrep.com/patent/US5348961A

## CPC

- C07D 231/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 215/56: with oxygen atoms in position 4
- C07D 233/56: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D 249/08: 1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy; R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial agents, which may be prepared by reacting a compound similar to that of formula (I) but in which R.sup.2 is replaced by a halogen atom with a compound providing the required group R.sup.2.

## Claims

### Claim 1

A compound of formula (I): ##STR20## in which R.sup.1 represents a methoxy group having at least one fluorine substituent;
R.sup.2 represents groups of formula (III): ##STR21## in which: R.sup.6 represents a hydrogen atom; a C.sub.1 -C.sub.6 alkyl group; a substituted C.sub.1 -C.sub.6 alkyl group having at least one substituent selected from the group consisting of substituents (b), defined below; a hydroxy group; a C.sub.1 -C.sub.6 alkoxy group; or a C.sub.1 -C.sub.6 alkoxy group having at least one fluorine substituent;
R.sup.7 represents a group of formula R.sup.8 R.sup.9 N-(CH.sub.2).sub.q -. in which R.sup.8 and R.sup.9 are independently selected from the group consisting of hydrogen atoms, C.sub.1 -C.sub.6 alkyl groups and aralkyl groups, and q represents 0 or 1; a hydroxy group; or a C.sub.1 -C.sub.6 alkoxy group;
B represents a methylene group, an ethylene group, a trimethylene group, or a tetramethylene group; and
n represents 1 or 2;
substituents (b) are selected from the group consisting of:
hydroxy groups, C.sub.1 -C.sub.6 alkoxy groups, and halogen atoms; and
said aralkyl groups have from 1 to 4 carbon atoms in the alkyl part and have an aryl part which has from 6 to 10 carbon atoms and which is unsubstituted or has at least one substituent selected from the group consisting of substituents (c), defined below;
substituents (c) are selected from the group consisting of:
hydroxy groups, C.sub.1 -C.sub.6 alkyl groups, C.sub.1 -C.sub.6 alkoxy groups, C.sub.2 -C.sub.6 aliphatic acyloxy groups, C.sub.2 -C.sub.6 aliphatic acyl groups, carboxy groups, C.sub.2 -C.sub.6 alkoxycarbonyl groups, sulfo groups, nitor groups, cyano groups, amino groups, C.sub.2 -C.sub.6 aliphatic acylamino groups, and mono- and di-(C.sub.1 -C.sub.6 alkyl) substituted amino groups;
or a pharmaceutically acceptable salt, ester or amide thereof.

### Claim 2 (depends on 1)

The compound of claim 1, wherein R.sup.2 represents a group of formula (IIIa): ##STR22## in which: R.sup.6' represents a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms; B' represents a methylene group or an ethylene group; and n is as defined in claim 1.

### Claim 3 (depends on 1)

The compound of claim 1, wherein R.sup.2 represents a group of formula (IIIb): ##STR23## in which R.sup.6, R.sup.8, R.sup.9, n and q are as defined in claim 1 and B' represents a methylene group or an ethylene group.

### Claim 4 (depends on 1)

The compound of claim 1, wherein R.sup.2 represents a group of formula (IIIc): ##STR24## in which: R.sup.11 and R.sup.12 are independently selected from the group consisting of hydroxy groups and alkoxy groups having from 1 to 3 carbon atoms.

### Claim 5 (depends on 1)

The compound of claim 1, wherein R1 represents a difluoromethoxy group or a trifluoromethoxy group.

### Claim 6 (depends on 1)

The compound of claim 1, wherein R.sup.1 represents a difluoromethoxy group or a trifluoromethoxy group and R.sup.2 represents a group of formula (IIIa): ##STR25## in which: R.sup.6' represents a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms; B' represents a methylene group or an ethylene group; and n is as defined in claim 1.

### Claim 7 (depends on 1)

The compound of claim 1, wherein R.sup.1 represents a difluoromethoxy group or a trifluoromethoxy group and R.sup.2 represents a group of formula (IIIb): ##STR26## in which R.sup.6, R.sup.8, R.sup.9, n and q are as defined in claim 1 and B' represents a methylene group or an ethylene group.

### Claim 8 (depends on 1)

The compound of claim 1, wherein R.sup.1 represents a difluoromethoxy group or a trifluoromethoxy group and R.sup.2 represents a group of formula (IIIc): ##STR27## in which: R.sup.11 and R.sup.12 are independently selected from the group consisting of hydroxy groups and alkoxy groups having from 1 to 3 carbon atoms.

### Claim 9 (depends on 1)

The compound of claim 1 selected from the group consisting of 1-cyclopropyl-8-difluoromethoxy-6-fluoro-7-(3-amino-1-pyrrolidinyl)-1,4-di hydro-4-oxoquinoline-3-carboxylic acid and pharmaceutically acceptable salts, esters and amides thereof.

### Claim 10 (depends on 1)

The compound of claim 1 selected from the group consisting of 5-amino-1-cyclopropyl-8-difluoromethoxy-6-fluoro-7-(3-amino-1-pyrrolidinyl )-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and pharmaceutically acceptable salts, esters and amides thereof.

### Claim 11 (depends on 1)

A pharmaceutical composition for the treatment of bacterial infections, comprising an effective amount of an antibacterial agent in combination with a pharmaceutically acceptable carrier or diluent, wherein the antibacterial agent is selected from the group consisting of compounds of formula (I) and pharmaceutically acceptable salts, esters and amides thereof, as claimed in claim 1.

### Claim 12 (depends on 11)

The composition of claim 11 wherein said antibacterial agent is selected from the group consisting of 1-cyclopropyl-8-difluoromethoxy-6-fluoro-7-(3-amino-1-pyrrolidinyl)-1,4-di hydro-4-oxoquinoline-3-carboxylic acid; 5-amino-1-cyclopropyl-8-difluoromethoxy-6-fluoro-7-(3-amino-1-pyrrolidinyl )-1-4-dihydro-4-oxoquinoline-3-carboxylic acid and pharmaceutically acceptable salts, esters and amides thereof.

### Claim 13 (depends on 1)

A method for the treatment or prophylaxis of bacterial infection comprising administering an amount of an antibacterial agent to an animal sufficient to exert an antibacterial effect, wherein said antibacterial agent is selected from the group consisting of compounds of formula (I) and pharmaceutically acceptable salts, esters and amides thereof, as claimed in claim 1.

### Claim 14 (depends on 13)

The method of claim 13 wherein said antibacterial agent is selected from the group consisting of 1-cyclopropyl-8-difluoromethoxy-6-fluoro-7-(3-amino-1-pyrrolidinyl)-1,4-di hydro-4-oxoquinoline-3-carboxylic acid; 5-amino-1-cyclopropyl-8-difluoromethoxy-6-fluoro-7-(3-amino-1-pyrrolidinyl )-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and pharmaceutically acceptable salts, esters and amides thereof.